Century Therapeutics IPSC
NASDAQ IPSC
$1.71 +0.06 (+3.64%)
At close: Sep 30, 2026 · 4:00 PM EDT

Century Therapeutics (IPSC) Liabilities and Shareholders Equity (2020 - 2026)

Updated

Century Therapeutics (IPSC) reported Liabilities and Shareholders Equity of $287.01 million for Q2 2026, up 0.8% from $284.69 million a year earlier but down 12.1% from the prior quarter.

Analysis

Century Therapeutics (IPSC) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

At the end of FY2025, Century Therapeutics posted Liabilities and Shareholders Equity of $223.7 million, down 36.7% from FY2024.

  • Liabilities and Shareholders Equity has declined for three consecutive years, though with a five-year compound annual growth rate of 15.9% (FY2020 to FY2025).
  • By year, Liabilities and Shareholders Equity came in at $353.22 million in FY2024 (-2.1%), $360.69 million in FY2023 (-25.9%), $486.54 million in FY2022 (+11.2%) and $437.38 million in FY2021 (+309.6%).
  • Five-year quarterly Liabilities and Shareholders Equity spans a low of $223.7 million in Q4 2025 and a high of $550.31 million in Q1 2022.
  • Year over year, Liabilities and Shareholders Equity gained in two of the last eight quarters, with an average decline of 14.4%.
  • The high point for year-over-year Liabilities and Shareholders Equity in five years was Q4 2021 (growth of 309.6%); the low point was Q3 2025 (a decline of 37.0%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $326.55 million (Q1 2026), $223.7 million (Q4 2025) and $244.72 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Century Therapeutics 308.74 Mn -195.64 Mn - 287.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 287.01 Mn
Mar 31, 2026 326.55 Mn
Dec 31, 2025 223.70 Mn
Sep 30, 2025 244.72 Mn
Jun 30, 2025 284.69 Mn
Mar 31, 2025 315.61 Mn
Dec 31, 2024 353.22 Mn
Sep 30, 2024 388.62 Mn
Jun 30, 2024 416.45 Mn
Mar 31, 2024 348.51 Mn
Dec 31, 2023 360.69 Mn
Sep 30, 2023 397.55 Mn
Jun 30, 2023 417.16 Mn
Mar 31, 2023 456.23 Mn
Dec 31, 2022 486.54 Mn
Sep 30, 2022 511.75 Mn
Jun 30, 2022 532.58 Mn
Mar 31, 2022 550.31 Mn
Dec 31, 2021 437.38 Mn
Sep 30, 2021 469.73 Mn
API Access

Century Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=IPSC&period=max&api_key=YOUR_API_KEY